Albany Molecular Research Overview

Albany Molecular Research EBIT

EBIT (Earnings Before Interest and Taxes) analysis for AMRI.

Quarterly EBIT

-$3.04M

↓ 477.14% YoY

As of Jun 30, 2017

Annual EBIT (TTM)

-$17.44M

↓ 673.87% YoY

Trailing 12 months ending Jun 30, 2017

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin